Italfarmaco Provides Givinostat Update (March 2019) Italfarmaco joined PPMD for a webinar on March 27, 2019 to update the community about Italfarmaco’s development of Givinostat and currently enrolling Phase 3 confirmatory study in Duchenne muscular dystrophy. Research & Clinical Trial Webinars,Webinars 6 years ago You may also like 1:04:29 A Closer Look at the Potential of CRISPR/Cas9 in Duchenne (December 2016) 8 years ago Research & Clinical Trial Webinars,Webinars gene therapy 43:10 NS Pharma’s Exon 53 Skipping Program (November 2016) 8 years ago Research & Clinical Trial Webinars,Webinars 47:28 Community Update Call: Sarepta & Summit (October 2016) 8 years ago Research & Clinical Trial Webinars,Webinars 47:33 SareptAssist Patient Services Overview (September 2016) 8 years ago Research & Clinical Trial Webinars,Webinars 1:24:01 PTC Therapeutics Provides Regulatory Update on Translarna (August 2016) 8 years ago Research & Clinical Trial Webinars,Webinars 1:00:59 What is CRISPR/Cas9? (July 2016) 8 years ago Research & Clinical Trial Webinars,Webinars gene therapy 43:52 MoveDMD: A Clinical Trial of Edasalonexent (CAT-1004) in Duchenne (June 2016) 9 years ago Research & Clinical Trial Webinars,Webinars 43:48 MissionDMD: FibroGen’s Anti-Fibrosis Program (May 2016) 9 years ago Research & Clinical Trial Webinars,Webinars «1…1819202122…25»Page 20 of 25
by: Parent Project Muscular Dystrophy
